Logo for Spero Therapeutics Inc

Spero Therapeutics Investor Relations Material

Latest events

Logo for Spero Therapeutics Inc

Q3 2023

Spero Therapeutics
Logo for Spero Therapeutics

Q3 2023

13 Nov, 2023
Logo for Spero Therapeutics

Investor Presentation

1 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. Their proprietary platform technology utilizes small molecules to target specific bacterial populations that are a major source of infection in critically ill patients or those with immune deficiencies.